SUBCUTANEOUS IGF-1 IS NOT BENEFICIAL IN 2-YEAR ALS TRIAL
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- October 13, 2009
has subject area
- 1103 Clinical Sciences (FoR)
- 1109 Neurosciences (FoR)
- 1702 Cognitive Sciences (FoR)
- Amyotrophic Lateral Sclerosis (MeSH)
- Animals (MeSH)
- Clinical Trials as Topic (MeSH)
- Humans (MeSH)
- Injections, Subcutaneous (MeSH)
- Insulin-Like Growth Factor I (MeSH)
- Neurology & Neurosurgery (Science Metrix)
published in
- Neurology Journal